Telesis Bio Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Telesis Bio Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2024.
  • Telesis Bio Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$704K, a 37.5% decline year-over-year.
  • Telesis Bio Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$1.07M, a 11.7% increase year-over-year.
  • Telesis Bio Inc. annual Nonoperating Income (Expense) for 2023 was -$1.16M, a 40.8% increase from 2022.
  • Telesis Bio Inc. annual Nonoperating Income (Expense) for 2022 was -$1.96M, a 45% increase from 2021.
  • Telesis Bio Inc. annual Nonoperating Income (Expense) for 2021 was -$3.57M, a 117% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.07M -$704K -$192K -37.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$882K -$69K +$248K +78.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$1.13M -$114K +$31K +21.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$1.16M -$187K +$55K +22.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$1.22M -$512K +$545K +51.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$1.76M -$317K +$21K +6.21% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1.78M -$145K +$180K +55.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$1.96M -$242K +$148K +37.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$2.11M -$1.06M -$678K -179% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.43M -$338K +$1.29M +79.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$2.72M -$325K +$849K +72.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$3.57M -$390K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$379K -$216K -133% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$1.63M -$841K -107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$1.17M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 -$163K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$786K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.